{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T07:43:22Z","timestamp":1762674202989,"version":"build-2065373602"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HL51971","HL124715","HL78147","HL105324","HD067541"],"award-info":[{"award-number":["HL51971","HL124715","HL78147","HL105324","HD067541"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002584","name":"American Historical Association","doi-asserted-by":"publisher","award":["14SDG20160020"],"award-info":[{"award-number":["14SDG20160020"]}],"id":[{"id":"10.13039\/100002584","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Prostaglandins &amp; Other Lipid Mediators"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.prostaglandins.2017.09.004","type":"journal-article","created":{"date-parts":[[2017,9,22]],"date-time":"2017-09-22T18:01:08Z","timestamp":1506103268000},"page":"108-113","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Selective inhibition of 20-hydroxyeicosatetraenoic acid lowers blood pressure in a rat model of preeclampsia"],"prefix":"10.1016","volume":"134","author":[{"given":"Jessica L.","family":"Faulkner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole L.","family":"Plenty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kedra","family":"Wallace","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorena M.","family":"Amaral","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark W.","family":"Cunningham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sydney","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Babbette","family":"LaMarca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.prostaglandins.2017.09.004_bib0005","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.bpobgyn.2011.01.006","article-title":"Epidemiology of pre-eclampsia and the other hypertensive disorders of pregnancy","volume":"25","author":"Hutcheon","year":"2011","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"issue":"2","key":"10.1016\/j.prostaglandins.2017.09.004_bib0010","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/ncpneph0035","article-title":"Mechanisms of disease: pre-eclampsia, nature clinical practice","volume":"1","author":"Noris","year":"2005","journal-title":"Nat. Clin. Pract. Nephrol."},{"issue":"3","key":"10.1016\/j.prostaglandins.2017.09.004_bib0015","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0146-0005(03)00022-3","article-title":"What we have learned about preeclampsia","volume":"27","author":"Sibai","year":"2003","journal-title":"Semin. Perinatol."},{"issue":"5","key":"10.1016\/j.prostaglandins.2017.09.004_bib0020","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/j.1552-6909.2010.01172.x","article-title":"A historical overview of preeclampsia-eclampsia","volume":"39","author":"Bell","year":"2010","journal-title":"J. Obstet. Gynecol. Neonatal Nurs.: JOGNN\/NAACOG"},{"issue":"1","key":"10.1016\/j.prostaglandins.2017.09.004_bib0025","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1177\/107155760000700105","article-title":"Preeclampsia prevention and management","volume":"7","author":"Norwitz","year":"2000","journal-title":"J. Soc. Gynecol. Investig."},{"issue":"4","key":"10.1016\/j.prostaglandins.2017.09.004_bib0030","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1152\/physiol.00006.2013","article-title":"Elucidating immune mechanisms causing hypertension during pregnancy","volume":"28","author":"LaMarca","year":"2013","journal-title":"Physiology"},{"issue":"6","key":"10.1016\/j.prostaglandins.2017.09.004_bib0035","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1042\/CS20150702","article-title":"The role of inflammation in the pathology of preeclampsia","volume":"130","author":"Harmon","year":"2016","journal-title":"Clin. Sci. (Lond.)"},{"issue":"1","key":"10.1016\/j.prostaglandins.2017.09.004_bib0040","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1152\/ajpregu.00052.2016","article-title":"Identifying immune mechanisms mediating the hypertension during preeclampsia","volume":"311","author":"LaMarca","year":"2016","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"issue":"1","key":"10.1016\/j.prostaglandins.2017.09.004_bib0045","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1152\/physrev.00021.2001","article-title":"P-450 metabolites of arachidonic acid in the control of cardiovascular function","volume":"82","author":"Roman","year":"2002","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.prostaglandins.2017.09.004_bib0050","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.prostaglandins.2016.05.007","article-title":"The role of 20-HETE in cardiovascular diseases and its risk factors","volume":"125","author":"Waldman","year":"2016","journal-title":"Prostaglandins Other Lipid Mediat."},{"issue":"6","key":"10.1016\/j.prostaglandins.2017.09.004_bib0055","doi-asserted-by":"crossref","first-page":"4118","DOI":"10.1074\/jbc.275.6.4118","article-title":"Formation of 20-hydroxyeicosatetraenoic acid, a vasoactive and natriuretic eicosanoid, in human kidney. Role of Cyp4F2 and Cyp4A11","volume":"275","author":"Lasker","year":"2000","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.prostaglandins.2017.09.004_bib0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/CRD.0b013e3182961659","article-title":"20-HETE and blood pressure regulation: clinical implications","volume":"22","author":"Wu","year":"2014","journal-title":"Cardiol. Rev."},{"issue":"6","key":"10.1016\/j.prostaglandins.2017.09.004_bib0065","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1007\/s00424-010-0804-6","article-title":"Epoxyeicosatrienoic acids and endothelium-dependent responses","volume":"459","author":"Campbell","year":"2010","journal-title":"Pflugers Archiv: Eur. J. Physiol."},{"issue":"4","key":"10.1016\/j.prostaglandins.2017.09.004_bib0070","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1472-8206.2008.00610.x","article-title":"Contribution of endothelium-derived hyperpolarizing factors to the regulation of vascular tone in humans","volume":"22","author":"Bellien","year":"2008","journal-title":"Fundam. Clin. Pharmacol."},{"issue":"1","key":"10.1016\/j.prostaglandins.2017.09.004_bib0075","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.tips.2006.11.002","article-title":"Beyond vasodilatation: non-vasomotor roles of epoxyeicosatrienoic acids in the cardiovascular system","volume":"28","author":"Larsen","year":"2007","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.prostaglandins.2017.09.004_bib0080","doi-asserted-by":"crossref","first-page":"239","DOI":"10.3389\/fphar.2014.00239","article-title":"Inside epoxyeicosatrienoic acids and cardiovascular disease","volume":"5","author":"Tacconelli","year":"2014","journal-title":"Front. Pharmacol."},{"issue":"2","key":"10.1016\/j.prostaglandins.2017.09.004_bib0085","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.gene.2012.02.029","article-title":"Disturbed ratio of renal 20-HETE\/EETs is involved in androgen-induced hypertension in cytochrome P450 4F2 transgenic mice","volume":"505","author":"Liu","year":"2012","journal-title":"Gene"},{"issue":"11","key":"10.1016\/j.prostaglandins.2017.09.004_bib0090","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1161\/CIRCRESAHA.116.310525","article-title":"20-HETE signals through G-protein-coupled receptor GPR75 (Gq) to affect vascular function and trigger hypertension","volume":"120","author":"Garcia","year":"2017","journal-title":"Circ. Res."},{"issue":"2","key":"10.1016\/j.prostaglandins.2017.09.004_bib0095","doi-asserted-by":"crossref","first-page":"R383","DOI":"10.1152\/ajpregu.2002.282.2.R383","article-title":"Renal 20-hydroxyeicosatetraenoic acid synthesis during pregnancy","volume":"282","author":"Wang","year":"2002","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"issue":"3","key":"10.1016\/j.prostaglandins.2017.09.004_bib0100","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1161\/01.HYP.0000117721.83371.9f","article-title":"Cytochrome P-450 inhibition attenuates hypertension induced by reductions in uterine perfusion pressure in pregnant rats","volume":"43","author":"Llinas","year":"2004","journal-title":"Hypertension"},{"issue":"25","key":"10.1016\/j.prostaglandins.2017.09.004_bib0105","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1161\/CIRCULATIONAHA.112.127340","article-title":"Cytochrome P450 subfamily 2J polypeptide 2 expression and circulating epoxyeicosatrienoic metabolites in preeclampsia","volume":"126","author":"Herse","year":"2012","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.prostaglandins.2017.09.004_bib0110","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1093\/ajh\/hps011","article-title":"Maternal and fetal epoxyeicosatrienoic acids in normotensive and preeclamptic pregnancies","volume":"26","author":"Jiang","year":"2013","journal-title":"Am. J. Hypertens."},{"issue":"4","key":"10.1016\/j.prostaglandins.2017.09.004_bib0115","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1097\/FJC.0b013e3181f04b1c","article-title":"20-Hydroxyeicosatetraeonic acid: a new target for the treatment of hypertension","volume":"56","author":"Williams","year":"2010","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"8","key":"10.1016\/j.prostaglandins.2017.09.004_bib0120","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1111\/bph.12079","article-title":"Treatment with the cytochrome P450 omega-hydroxylase inhibitor HET0016 attenuates cerebrovascular inflammation, oxidative stress and improves vasomotor function in spontaneously hypertensive rats","volume":"168","author":"Toth","year":"2013","journal-title":"Br. J. Pharmacol."},{"issue":"10","key":"10.1016\/j.prostaglandins.2017.09.004_bib0125","doi-asserted-by":"crossref","first-page":"e26063","DOI":"10.1371\/journal.pone.0026063","article-title":"Role of 20-hydroxyeicosatetraenoic acid in mediating hypertension in response to chronic renal medullary endothelin type B receptor blockade","volume":"6","author":"Speed","year":"2011","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.prostaglandins.2017.09.004_bib0130","doi-asserted-by":"crossref","first-page":"H541","DOI":"10.1152\/ajpheart.01113.2007","article-title":"Pathophysiology of hypertension during preeclampsia: linking placental ischemia with endothelial dysfunction","volume":"294","author":"Gilbert","year":"2008","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"4","key":"10.1016\/j.prostaglandins.2017.09.004_bib0135","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1161\/01.HYP.37.4.1191","article-title":"Reduced uterine perfusion pressure during pregnancy in the rat is associated with increases in arterial pressure and changes in renal nitric oxide","volume":"37","author":"Alexander","year":"2001","journal-title":"Hypertension"},{"key":"10.1016\/j.prostaglandins.2017.09.004_bib0140","first-page":"383","article-title":"Reduced uterine perfusion pressure (RUPP) model for studying cardiovascular-renal dysfunction in response to placental ischemia","volume":"122","author":"Granger","year":"2006","journal-title":"Methods Mol. Med."},{"issue":"1","key":"10.1016\/j.prostaglandins.2017.09.004_bib0145","doi-asserted-by":"crossref","first-page":"R125","DOI":"10.1152\/ajpregu.00218.2016","article-title":"Vitamin D supplementation reduces some AT1-AA-induced downstream targets implicated in preeclampsia including hypertension, American journal of physiology","volume":"312","author":"Faulkner","year":"2017","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"issue":"12","key":"10.1016\/j.prostaglandins.2017.09.004_bib0150","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.2174\/15680266113139990110","article-title":"CYP4 enzymes as potential drug targets: focus on enzyme multiplicity, inducers and inhibitors, and therapeutic modulation of 20-hydroxyeicosatetraenoic acid (20-HETE) synthase and fatty acid omega-hydroxylase activities","volume":"13","author":"Edson","year":"2013","journal-title":"Curr. Top. Med. Chem."},{"issue":"12","key":"10.1016\/j.prostaglandins.2017.09.004_bib0155","doi-asserted-by":"crossref","first-page":"e82482","DOI":"10.1371\/journal.pone.0082482","article-title":"20-Hydroxyeicosatetraenoic acid contributes to the inhibition of K+ channel activity and vasoconstrictor response to angiotensin II in rat renal microvessels","volume":"8","author":"Fan","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.prostaglandins.2017.09.004_bib0160","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.prostaglandins.2013.03.001","article-title":"Endogenously produced 20-HETE modulates myogenic and TGF response in microperfused afferent arterioles","volume":"102\u2013103","author":"Ge","year":"2013","journal-title":"Prostaglandins Other Lipid Mediat."},{"issue":"3","key":"10.1016\/j.prostaglandins.2017.09.004_bib0165","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1161\/01.RES.78.3.415","article-title":"Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors","volume":"78","author":"Campbell","year":"1996","journal-title":"Circ. Res."},{"issue":"6752","key":"10.1016\/j.prostaglandins.2017.09.004_bib0170","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/46816","article-title":"Cytochrome P450 2C is an EDHF synthase in coronary arteries","volume":"401","author":"Fisslthaler","year":"1999","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.prostaglandins.2017.09.004_bib0175","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1161\/01.CIR.0000047278.28407.C2","article-title":"Endothelium-derived hyperpolarizing factor in human internal mammary artery is 11,12-epoxyeicosatrienoic acid and causes relaxation by activating smooth muscle BK(Ca) channels","volume":"107","author":"Archer","year":"2003","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.prostaglandins.2017.09.004_bib0180","doi-asserted-by":"crossref","first-page":"E647","DOI":"10.1152\/ajpendo.00227.2009","article-title":"Detection of EETs and HETE-generating cytochrome P-450 enzymes and the effects of their metabolites on myometrial and vascular function","volume":"297","author":"Pearson","year":"2009","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.prostaglandins.2017.09.004_bib0185","doi-asserted-by":"crossref","first-page":"E691","DOI":"10.1152\/ajpendo.00710.2010","article-title":"Soluble epoxide hydrolase in the generation and maintenance of high blood pressure in spontaneously hypertensive rats","volume":"300","author":"Koeners","year":"2011","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"7","key":"10.1016\/j.prostaglandins.2017.09.004_bib0190","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1042\/CS20130003","article-title":"Role of haem oxygenase in the renoprotective effects of soluble epoxide hydrolase inhibition in diabetic spontaneously hypertensive rats","volume":"125","author":"Elmarakby","year":"2013","journal-title":"Clin. Sci. (Lond.)"}],"container-title":["Prostaglandins &amp; Other Lipid Mediators"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098882317300941?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098882317300941?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T01:59:50Z","timestamp":1761098390000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098882317300941"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":38,"alternative-id":["S1098882317300941"],"URL":"https:\/\/doi.org\/10.1016\/j.prostaglandins.2017.09.004","relation":{},"ISSN":["1098-8823"],"issn-type":[{"type":"print","value":"1098-8823"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Selective inhibition of 20-hydroxyeicosatetraenoic acid lowers blood pressure in a rat model of preeclampsia","name":"articletitle","label":"Article Title"},{"value":"Prostaglandins & Other Lipid Mediators","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prostaglandins.2017.09.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}